Sign in

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

By Zenith Wang and others at
LogoRockefeller University
To date severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has infected over 100 million individuals resulting in over two million deaths. Many vaccines are being deployed to prevent coronavirus disease 2019 (COVID-19) including two novel mRNA-based vaccines1,2. These vaccines elicit neutralizing antibodies and appear to be safe and effective, but the... Show more
February 10, 2021
=
0
Loading PDF…
Loading full text...
Similar articles
Loading recommendations...
=
0
x1
mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants
Click on play to start listening